MacroGenics
MGNX
#8424
Rank
NZ$0.42 B
Marketcap
NZ$6.65
Share price
-6.05%
Change (1 day)
167.01%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.42 Billion

As of June 2026 MacroGenics has a market cap of NZ$0.42 Billion. This makes MacroGenics the world's 8424th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.42 B140.5%
2025NZ$0.17 B-51.08%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Jun 16th, 2026 the market cap of MacroGenics was reported to be:

NZ$0.42 Billion
by Nasdaq info icon info icon
NZ$0.42 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$254.51 B 60,077.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.716 T 405,771.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$321.94 B 76,020.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$270.89 B 63,950.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$487.80 B 115,236.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$195.82 B 46,202.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$1.55 B 266.76%๐Ÿ‡บ๐Ÿ‡ธ USA